A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
Clinical trial NCT01025570 · TERMINATED
Trial details
- NCT number
- NCT01025570
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.